Runzhe Chen
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Lung Cancer Research Studies
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 5
- Inflammatory Biomarkers in Disease Prognosis 3
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Baoan Chen (7 shared papers)Baoan Chen (8 shared papers)Hongming Zhang (3 shared papers)Chengxin Luan (4 shared papers)Ye Li (2 shared papers)Jinliang Wang (3 shared papers)Xiang Yan (3 shared papers)Zhibo Zhang (3 shared papers)
- Journals
- Drug Design Development and Therapy (4 papers)Journal of Cancer (3 papers)OncoTargets and Therapy (3 papers)Frontiers in Oncology (3 papers)Patient Preference and Adherence (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Runzhe Chen
37 papers receiving 498 citations
Peers
Comparison fields: 5 of 90
- Oncology 241
- Hematology 71
- Cancer Research 67
- Immunology 85
- Genetics 40
Countries citing papers authored by Runzhe Chen
This map shows the geographic impact of Runzhe Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runzhe Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runzhe Chen more than expected).
Fields of papers citing papers by Runzhe Chen
This network shows the impact of papers produced by Runzhe Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runzhe Chen. The network helps show where Runzhe Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Runzhe Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 66 | |
| 2 | 2015 | 55 | |
| 3 | 2015 | 50 | |
| 4 | 2020 | 33 | |
| 5 | 2015 | 28 | |
| 6 | 2017 | 27 | |
| 7 | 2020 | 26 | |
| 8 | 2017 | 24 | |
| 9 | 2019 | 20 | |
| 10 | 2016 | 17 | |
| 11 | 2015 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2021 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 8 | |
| 17 | 2015 | 7 | |
| 18 | 2015 | 7 | |
| 19 | 2023 | 6 | |
| 20 | CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia. | 2015 | 6 |
About Runzhe Chen
Runzhe Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Molecular Biology and Surgery, having authored 40 papers that have together received 502 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Multiple Myeloma Research and Treatments (5 papers), CAR-T cell therapy research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Lung Cancer Treatments and Mutations (4 papers), Protein Degradation and Inhibitors (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (241 citations), Hematology (71 citations), Cancer Research (67 citations), Immunology (85 citations) and Genetics (40 citations). Runzhe Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Baoan Chen, Baoan Chen, Hongming Zhang, Chengxin Luan, Ye Li, Jinliang Wang, Xiang Yan, Zhibo Zhang, Baoan Chen and Yi Hu. Their work appears in journals such as Drug Design Development and Therapy, Journal of Cancer, OncoTargets and Therapy, Frontiers in Oncology and Patient Preference and Adherence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.